Triple Negative Breast Cancer: Breast Cancer Research in EvolutionENG-WONG, Jennifer; ZUJEWSKI, Anne.Breast disease. 2011, Vol 32, Num 1-2, issn 0888-6008, 137 p.Serial Issue

Current NCI-sponsored Cooperative Group Trials of Endocrine Therapies in Breast CancerENG-WONG, Jennifer; ZUJEWSKI, Jo Anne.Cancer. 2008, Vol 112, Num 3, pp 723-729, issn 0008-543X, 7 p., SUPConference Paper

Mouse models of triple negative [basal-like-claudin low] breast cancerHERSCHKOWITZ, Jason I; LUBET, Ron.Breast disease. 2011, Vol 32, Num 1-2, pp 63-71, issn 0888-6008, 9 p.Article

Epidemiology of triple negative breast cancersGIERACH, Gretchen L; BURKE, Aileen; ANDERSON, William F et al.Breast disease. 2011, Vol 32, Num 1-2, pp 5-24, issn 0888-6008, 20 p.Article

Molecular profiling of triple negative breast cancerMA, Cynthia X; JINGQIN LUO; ELLIS, Matthew J et al.Breast disease. 2011, Vol 32, Num 1-2, pp 73-84, issn 0888-6008, 12 p.Article

BRCA1/2 mutations and triple negative breast cancersPESHKIN, Beth N; ALABEK, Michelle L; ISAACS, Claudine et al.Breast disease. 2011, Vol 32, Num 1-2, pp 25-33, issn 0888-6008, 9 p.Article

Effect of raloxifene on salivary sex steroid concentrations in premenopausal womenCHATTERTON, Robert T; ZUJEWSKI, Joanne; MATEO, Esnar T et al.Journal of endocrinology. 2006, Vol 191, Num 3, pp 599-604, issn 0022-0795, 6 p.Article

Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancerENG-WONG, Jennifer; HURSTING, Stephen D; VENZON, David et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 12, pp 1468-1473, issn 1055-9965, 6 p.Article

The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptomsSHANMUGAM, Victoria K; MCCLOSKEY, James; ELSTON, Beth et al.Breast cancer research and treatment. 2012, Vol 131, Num 2, pp 699-708, issn 0167-6806, 10 p.Article

Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancerCHAVEZ, Kathryn J; GARIMELLA, Sireesha V; LIPKOWITZ, Stanley et al.Breast disease. 2011, Vol 32, Num 1-2, pp 35-48, issn 0888-6008, 14 p.Article

Triple-negative breast cancers and the human mammary epithelial cell hierarchyGANESAN, Shridar; KARANTZA, Vassiliki; OZA, Jay et al.Breast disease. 2011, Vol 32, Num 1-2, pp 49-61, issn 0888-6008, 13 p.Article

Current treatment options in triple negative breast cancerRODLER, Eve; KORDE, Larissa; GRALOW, Julie et al.Breast disease. 2011, Vol 32, Num 1-2, pp 99-122, issn 0888-6008, 24 p.Article

BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancerDIAZ-CRUZ, Edgar S; CABRERA, Marina C; NAKLES, Rebecca et al.Breast disease. 2011, Vol 32, Num 1-2, pp 85-97, issn 0888-6008, 13 p.Article

Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancerFAUPEL-BADGER, Jessica M; PRINDIVILLE, Sheila A; VENZON, David et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 6, pp 1153-1158, issn 1055-9965, 6 p.Article

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancerISAACS, Claudine; HERBOLSHEIMER, Pia; CRESWELL, Karen et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 137-143, issn 0167-6806, 7 p.Article

Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancerGIERACH, Gretchen L; LOUD, Jennifer T; CALZONE, Kathleen A et al.Breast cancer research and treatment. 2010, Vol 123, Num 1, pp 245-255, issn 0167-6806, 11 p.Article

Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast CancerLIU, Minetta C; SHIELDS, Peter G; ISAACS, Claudine et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5153-5159, issn 0732-183X, 7 p.Article

Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast CancerENG-WONG, Jennifer; ORZANO-BIRGANI, Jennifer; CHOW, Catherine K et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 7, pp 1696-1701, issn 1055-9965, 6 p.Article

Patient Navigation Significantly Reduces Delays in Breast Cancer Diagnosis in the District of Columbia : Patient Navigation in Cancer CareHOFFMAN, Heather J; LAVERDA, Nancy L; HUERTA, Elmer et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 10, pp 1655-1663, issn 1055-9965, 9 p.Article

Clinical trials in triple negative breast cancerREEDER-HAYES, Katherine E; CAREY, Lisa A; SIKOV, William M et al.Breast disease. 2011, Vol 32, Num 1-2, pp 123-136, issn 0888-6008, 14 p.Article

The Impact of Systemic Therapy Following Ductal Carcinoma In SituENG-WONG, Jennifer; COSTANTINO, Joseph P; SWAIN, Sandra M et al.Journal of the National Cancer Institute. Monographs. 2010, Vol 41, pp 200-203, issn 1052-6773, 4 p.Conference Paper

Gynecologic and hormonal effects of raloxifene in premenopausal womenPREMKUMAR, Ahalya; VEFIZON, David J; AVILA, Nilo et al.Fertility and sterility. 2007, Vol 88, Num 6, pp 1637-1644, issn 0015-0282, 8 p.Article

A phase I trial and pharmacokinetic study of tipifarnib, a Farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancerLEBOWITZ, Peter F; ENG-WONG, Jennifer; WIDEMANN, Brigitte C et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1247-1252, issn 1078-0432, 6 p.Article

A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancerLEBOWITZ, Peter F; ENG-WONG, Jennifer; ZUJEWSKI, Joanne et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 6764-6769, issn 1078-0432, 6 p.Article

A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancerZUJEWSKI, Jo Anne; ENG-WONG, Jennifer; O'SHAUGHNESSY, Joyce et al.Breast cancer research and treatment. 2003, Vol 81, Num 1, pp 41-51, issn 0167-6806, 11 p.Article